{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:10:33Z","timestamp":1788261033884,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jmoldx.2019.11.002","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T12:47:33Z","timestamp":1576759653000},"page":"346-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Validation of Fragile X Screening in the Newborn Population Using a Fit-for-Purpose FMR1 PCR Assay System"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-0032","authenticated-orcid":false,"given":"Stacey","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5275-0001","authenticated-orcid":false,"given":"Charles","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Hadd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon A.","family":"Kemppainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Shone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-9330","authenticated-orcid":false,"suffix":"Jr.","given":"Donald B.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Latham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2019.11.002_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13052-017-0355-y","article-title":"Fragile X syndrome: a review of clinical and molecular diagnoses","volume":"43","author":"Ciaccio","year":"2017","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/gim.2013.61","article-title":"ACMG standards and guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the ACMG","volume":"15","author":"Monaghan","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/gm401","article-title":"FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States","volume":"4","author":"Tassone","year":"2012","journal-title":"Genome Med"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib4","first-page":"714","article-title":"Fragile X syndrome detection in newborns: pilot study","volume":"10","author":"Saul","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ajhg.2009.09.007","article-title":"Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA","volume":"85","author":"Coffee","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jmoldx.2013.02.006","article-title":"Fragile X screening by quantification of FMRP in dried blood spots by a luminex immunoassay","volume":"15","author":"LaFauci","year":"2013","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamaneurol.2014.142","article-title":"Methylation analysis in newborn screening for fragile X syndrome","volume":"71","author":"Godler","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jmoldx.2015.04.006","article-title":"Fragile X syndrome: scientific background and screening technologies","volume":"17","author":"Lyons","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijns4010009","article-title":"Are we ready for fragile X newborn screening testing?\u2014lessons learnt from a feasibility study","volume":"4","author":"Wotton","year":"2018","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1373\/clinchem.2008.111864","article-title":"Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders","volume":"55","author":"De Jesus","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib11","first-page":"1","article-title":"Dried blood spots: preparing and processing for use in immunoassays and in molecular techniques","volume":"97","author":"Gr\u00fcner","year":"2015","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib12","series-title":"Blood Collection on Filter Paper for Newborn Screening Programs: Approved Standard","year":"2013"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/gim.2014.209","article-title":"Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study","volume":"18","author":"Baker","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1373\/clinchem.2009.136101","article-title":"A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome","volume":"56","author":"Filipovic-Sadic","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2353\/jmoldx.2010.090227","article-title":"An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis","volume":"12","author":"Chen","year":"2010","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib16","series-title":"Molecular Methods for Clinical Genetics and Oncology Testing: Approved Guideline","year":"2012"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1542\/peds.2008-2992","article-title":"No change in the age of diagnosis for fragile X syndrome: findings from a National Parent Survey","volume":"124","author":"Bailey","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jmoldx.2019.11.002_bib18","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1542\/peds.2007-0820","article-title":"Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues","volume":"121","author":"Bailey","year":"2008","journal-title":"Pediatrics"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157819304520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157819304520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:13:49Z","timestamp":1761502429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157819304520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1525157819304520"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2019.11.002","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of Fragile X Screening in the Newborn Population Using a Fit-for-Purpose FMR1 PCR Assay System","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2019.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}